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There is substantial evidence for the central role of stress in the inception and 
maintenance of substance use disorders. The use of mindfulness training (MT) has 
demonstrated promise in a number of stress-related conditions. However, no studies to 
date have compared MT to empirically validated treatments such as cognitive behavioral 
therapy (CBT) for substance use disorders or assessed its impact on response to stress 
provocation. The specific aim of this investigation was to engage in the first randomized, 
controlled trial of a manualized mindfulness based therapy for the treatment of substance 
use disorders. The hypotheses to be tested were: (1) MT would be tolerated equally as 
effectively as CBT in terms of retention rates and subjective measures of treatment 
tolerability; (2) Participants undergoing MT would demonstrate reduced reactivity on 
both subjective and objective measures during stress provocation as compared with CBT; 
and (3) Participants undergoing MT would have reduced substance use as compared with 
CBT following completion of the intervention. 36 individuals with alcohol and/or cocaine 
use disorders were randomly assigned to receive group MT or CBT in an outpatient 
community setting. After treatment completion, subjective and physiologic responses to 
personalized stress provocation were measured by self report, skin conductance, heart 
rate, and heart rate variability. Subjects exposed to MT demonstrated reduced 
psychological and physiological indices of stress during provocation compared with 
subjects exposed to CBT, as evidenced by the laboratory paradigm conducted post-
 
treatment among treatment completers. There were no significant differences in retention, 
treatment satisfaction, or abstinence rates between individuals assigned to MT versus 
CBT. This pilot study provides preliminary evidence for the use of MT in targeting stress 
for substance use disorders.
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I. Introduction 
Over the past several decades, cognitive-behavioral approaches have become the most 
prevalent and widely researched of all evidence-based, non-pharmacologic interventions for 
substance use disorders (1). CBT’s prominence as a therapeutic modality is attributable to 
repeated demonstrations of its efficacy for reducing substance use in randomized clinical trials 
(2) as well as robust theoretical explanations for its mechanism of action. Specifically, the theory 
underlying the use of CBT in addictive disorders posits that deficits in the ability to cope with 
life stress in general and drug cues in particular serve to maintain excessive drug use and lead to 
a resumption of use following cessation attempts. The various forms of CBT all share some form 
of skills training to address cognitive and behavioral coping deficits,  including identification of 
specific situations where coping inadequacies occur, and the use of instruction, modeling, role-
plays and behavioral rehearsal to address these inadequacies. In their review of cognitive-
behavioral treatment for alcohol dependence, Morgenstern and Longabaugh summarize CBT’s 
strengths as follows: “A strong theoretical base, impressive efficacy data and weak evidence for 
effective alternative treatments have led to the ascendancy of CBT as the dominant paradigm for 
treating alcohol dependence within the research community” (2). 
More recently, however, preliminary evidence has also accumulated for the efficacy of 
mindfulness based therapies in the treatment of tobacco, alcohol, and drug use disorders (1, 3-8). 
For example, Zgierska and colleagues found significant reductions in anxiety, depression, and 
stress in individuals with alcohol dependence who were enrolled in an eight-week mindfulness 
meditation regimen after completing an intensive outpatient program (3). Bowen and colleagues 
reported significant reductions in alcohol and drug use after release from prison in individuals 
who had undergone a 10-day vipassana meditation course while incarcerated, compared to those 
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that had received treatment as usual (7). In seeking to understand the potential role for 
mindfulness based therapies in the treatment of substance use disorders, it is helpful to first 
establish a precise definition of mindfulness, and then discuss the theoretical links between 
mindfulness, stress reactivity, and addiction. This discussion will then be followed by a more 
general discussion of the theoretical basis for the use of mindfulness oriented therapies in the 
treatment of substance use disorders. 
As taught as a component of Buddhist philosophy for over two millennia, the practice of 
mindfulness involves an attitude of openness, inquisitiveness, and acceptance of moment-to-
moment experience (9-11). A recent consensus definition of mindfulness emphasizes two 
complementary elements: 1) the placement of attention on the immediate experience; and 2) 
adopting an open, curious, accepting attitude toward that experience (9). The premise behind 
cultivating mindfulness is that observing one’s immediate circumstances with an open attitude of 
acceptance is helpful for identifying automatic, habitual patterns of reactivity to internal and 
external events as they arise. This perspective, in turn, allows one to learn to respond more 
intentionally to environmental stimuli rather than thoughtlessly reacting. While the terms 
meditation and mindfulness are occasionally used interchangeably, they do not refer to the same 
concept. Rather, meditation is a specific technique or practice that has been used to cultivate the 
quality of mindfulness over time (12). 
According to Buddhist philosophy, one of the primary effects of continued mindfulness 
practice is the development of awareness regarding the ever-changing nature of reality, whether 
in terms of the physical body, internal states, or external circumstances. Through this awareness 
comes greater understanding of how one’s views of reality may clash with actual events, 
resulting in discord and suffering. With these insights and gradual nonjudgmental acceptance of 
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experience comes greater skill at releasing habitual thought patterns or behaviors that may 
contribute to various psychological conditions, such as depression or substance addiction, thus 
providing a possible means by which to decrease one’s suffering. 
While meditation has been practiced for thousands of years in the East, it did not come to 
the attention of Western medical science until much more recently. Specifically, a seminal study 
published by Goleman and Schwartz in 1976 reported that meditation experience helped to 
reduce stress reactivity—i.e., cognitive and physiological reactions to stress (13). The 
investigators reported that when exposed to disturbing video images of death and 
dismemberment, experienced meditators demonstrated attenuated heart rate and phasic skin 
conductance responses as well as less subjective anxiety when compared with subjects who had 
no experience with meditation. These findings led them to conclude that “meditation can produce 
a psychophysiological configuration in stress situations opposite to that seen in stress-related 
syndromes” (13). Just three years later, one of the first meditation-based treatment modalities 
was developed through the outpatient Stress Reduction Clinic at the University of Massachusetts 
Medical Center. This modality, known as Mindfulness-Based Stress Reduction (MBSR), was 
developed as an adjunct to medical care and intended to optimize health outcomes for people 
with chronic medical problems (14). Mindfulness based therapies such as MBSR and 
Mindfulness-Based Cognitive Therapy (MBCT) are sometimes referred to generically as 
“Mindfulness Training” (MT). 
It is believed that while the capacity for mindfulness is inherent, without MT or specific 
meditation practices the majority of individuals move through life on “auto-pilot” (10) and 
perform daily activities based on habitual behavioral patterns while their minds are elsewhere 
(e.g., thinking about the past or worrying about future experiences) rather than purposefully 
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focusing attention on the present moment. Mindfulness is developed through the continual 
practice of “awakening” to present-moment experiences. Traditionally, this skill is taught 
through meditation exercises that focus on developing concentration capacities by repeatedly 
bringing attention to a specific object (e.g., the touch sensation of one’s breath as it flows in and 
out of the nostrils), then broadening it to include all physical and mental events that are 
consciously experienced (e.g., bodily sensations, emotions, and thoughts). Instruction for 
mindfulness practice can be as simple as: “When sitting, know you are sitting; when walking, 
know you are walking; when thinking, know you are thinking.” 
While the basic instructions for mindfulness practice appear quite straightforward, Jon 
Kabat-Zinn, the developer of MBSR and one of the central figures responsible for the elucidation 
of mindfulness’ clinical applications in general, has described the challenges surrounding its 
actual employment: “Detached self-observation is not a trivial task. The mind has a strong 
tendency to wander and invariably becomes preoccupied with the content of thoughts and 
emotions, which often take form as memories, anticipations, ideas, opinions, and desires. The 
result is a reduction or complete loss of moment-to-moment attention and observation. When 
recognition of this drift from awareness occurs, the meditator simply brings attention to a detail 
of momentary reality, usually the breath or a sensation, to (re)anchor the attention in the present. 
When the faculty of detached observation becomes stable, the field of awareness is allowed to 
expand again. With practice, any event that arises in the field of one’s awareness momentarily 
becomes the object of meditation until the next event (which may also be the experience of 
“absence of event”) arises. In awareness meditation practice, no event is considered a distraction 
(not even the wandering of the mind); it is simply another object of observation.” (15). 
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Mindfulness has been operationalized to include the two distinct components described in 
the consensus definition above: 1) attention that is maintained on the immediate experience, and 
2) the maintenance of an attitude of acceptance/non-judgment towards the object of attention (9). 
Recent studies have suggested that as few as 8 weeks of MT can have direct and measurable 
effects on both attentional processes as well as neuronal activation (16, 17). The format of MT 
generally follows an 8 to 10-week schedule, with groups usually composed of 10–40 participants 
who meet for single 1.5- to 2.5-hour sessions each week occurring in a sequential order (18). 
During a standard course of MBSR, each session would include experiential meditation practice 
as well as an educational/discussion component. Meditation exercises that might be used during 
these sessions include mindful body scanning, sitting meditation, walking meditation, and basic 
yoga. Participants are encouraged by the facilitator to be increasingly mindful in their day-to-day 
activities, such as when eating a meal, and to practice meditation between sessions (18). 
Since the early days of research into meditation’s “psychophysiological” effects, the 
more standardized mindfulness oriented therapies such as MBSR (15) and MBCT (19) have 
demonstrated efficacy in the treatment of a wide variety of stress-related disorders, including 
anxiety (20), depression (19, 21), chronic pain (11), insomnia (22), eating disorders (23, 24), 
suicidality (25, 26), and even psoriasis (which can be exacerbated by psychological stress) (27). 
MBCT for prevention of relapse in depression has shown an absolute reduction of 44-50% in the 
relapse/recurrence rate for those with three or more episodes of depression in both initial and 
replication studies (19, 21). 
Given the accumulating evidence of MT’s efficacy in the treatment of stress-related 
conditions, as well as the established importance of stress reactivity in the inception and 
maintenance of addiction (28-32), researchers have more recently begun to investigate a 
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potential role for MT in the treatment of substance use disorders, with some preliminary 
evidence of promise as described above. There is substantial theoretical rationale for attempting 
to use MT to target stress reactivity in patients with substance use disorders. Considerable 
clinical evidence suggests that exposure to stress can produce an increased arousal state similar 
to that induced by drug cues (33). Furthermore, preclinical data  suggest that acute stress may 
provoke an increase in self-administration of drugs such as amphetamines (34), cocaine (35, 36), 
and alcohol (37, 38). These findings are consistent with incentive conditioning models, which 
suggest that exposure to drug-related cues produce conditioned responses, which in turn serve as 
a cue for subsequent drug-seeking behavior and substance use (39). 
Additionally, as drugs have been shown to activate stress circuitry, and hypothalamic-
pituitary-adrenal (HPA) activation has been shown to reciprocally increase mesolimbic 
dopamine transmission, exposure to stress may provide a common neural substrate by which 
stress enhances drug-seeking behavior and relapse risk (29, 33). Not surprisingly, stressful events 
and psychological distress are frequently cited reasons for relapse to drug use among individuals 
with substance use disorders (30, 40-42). These data support the hypothesis that mechanisms 
related to stress are critical in the establishment of addictions and their continued propagation as 
chronic disorders (43, 44). 
Beyond MT’s obvious role in targeting stress reactivity, newer research suggests that 
mindfulness oriented therapies may act on other pathways and neuroanatomic regions that are 
important in the pathophysiology of addictions. The remainder of this introduction will review the 
recent research regarding these other pathways as well as theoretical justifications for the use of 
mindfulness oriented therapies in the treatment of substance use disorders.  
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Intentional, sustained attention on a chosen focus is a core practice in mindfulness 
meditation. As described in the quote by Kabat-Zinn above, whenever the mind strays from the 
object of attention or is distracted by other stimuli, the meditator is instructed to gently bring his 
or her attention back to the intended focus. This practice could be described as targeting 
stimulus-independent thought (SIT). SIT refers to automatically generated verbal or visual 
experience, “stream of consciousness” (10, 45, 46), or the default tendency to have “narrative 
process” when there is no demand to respond to external stimuli (47). The medial prefrontal 
cortex (mPFC) has been shown to play a role in linking subjective experiences through time (48, 
49), holding memory of traits of the self (50, 51), reflected self-knowledge (52, 53), and 
aspirations for the future (54). These findings suggest that midline cortical structures are 
involved in producing a “narrative self reference,” or a sense of identity through time (55, 56). 
Brain activation in midline cortical structures during narrative self-reference has shown 
similarities with the proposed “default mode” of resting attention (57, 58). Thus, it appears that a 
“wandering mind” prone to SIT may be the default mental state even in the absence of external 
stimuli. 
The mechanisms by which mindfulness training influences narrative self-
reference/default mode functioning are the subject of current investigation. In one recent study, 
participants were instructed to either elaborate on current cognitions (narrative focus, NF) or to 
attend to somatic sensations and merely note the presence of any cognitions without elaborating 
on them (experiential focus, EF). The investigators found increased midline cortical activation 
with the NF condition as compared to EF (17). Indeed, after eight weeks of mindfulness training, 
midline cortical structures showed decreased activity in EF vs. NF (17). One interpretation of 
these data is that momentary self-experience may provide a non-self-related cortical “task” 
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which may lead to suppression of midline cortical activity. These findings are corroborated by 
behavioral studies showing improved attentional regulation with meditation training (16, 59, 60). 
Another study demonstrated a correlation between trait mindfulness and reduced amygdalar 
activation during affect labeling (matching facial expressions with corresponding affect words) 
(61). Together, these data suggest that present-centered attentional focus not only moves the 
individual away from the habitual default-mode thought process, but also manifests itself in 
behavioral processes. 
The link between attention training and treatment of depression and addiction may not be 
initially apparent. It has been hypothesized that focusing and sustaining attention on present 
experience increases the ability to notice overlearned behavioral patterns as they arise, allowing 
for individualized interventions (whether cognitive, emotional, or behavioral) that interrupt the 
cyclical nature of these patterns (1, 9, 62). For example, preliminary findings suggest efficacy of 
mindfulness-based treatment for obsessive compulsive disorder (OCD, a disorder characterized 
by overly active habit-related neural networks). Treatment response has been positively 
correlated with decreases in overactive brain regions such as the dorsal striatum, suggesting that 
mindfulness may modulate these pathways, leading to fewer compulsive behaviors (63).  
Similar cognitive habit patterns are reflected in the rumination that often occurs in 
clinical depression. Early in the course of major depressive episodes, associations between 
depressed mood and depressive, negativistic thought patterns are established, and these can be 
reactivated during periods of dysphoria (64, 65). Ruminative patterns can then precipitate future 
depressive episodes (66, 67). With continued practice of mindfulness, individuals may be better 
able to notice these patterns, allowing for disengagement from the thoughts (i.e., not being 
caught up in the thoughts and thus believing them to be “true”) and an increased sense of choice 
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as to how to relate to the experience, rather than automatically following the thoughts (typically 
into deepening dysphoria) (10, 68). Studies have shown that decreases in distress scores 
following mindfulness training are mediated by a decreased tendency to ruminate (69). It is 
posited that similar mechanisms may operate in the relationship between mindfulness practice 
and the prevention of relapse to depression, especially given repeated observation of its 
effectiveness in individuals with three or more depressive episodes, but not in those with fewer. 
These findings suggest mindfulness practices may be effective in targeting more habitual 
patterns or ruminative thinking, rather than situational depression (19, 21).  
Efforts to avoid or suppress “unwanted” thoughts are commonly used in patients’ 
attempts to manage cravings and relapse (70). However, these strategies may in fact be 
counterproductive. For example, thought suppression has been shown to lead to stronger 
expectancies after cue exposure (71). Interestingly, decreases in alcohol consumption following 
mindfulness-based treatment have been shown to be partially mediated by decreases in thought 
suppression indices such as avoidance (4). These findings suggest that bringing attentional focus 
to arising thoughts may be more effective than attempts to suppress them in decreasing their 
influence on behavior. This intentional focus correlates with changes in activation of midline 
cortical structures in healthy volunteers (17). A similar mechanism is hypothesized to exist in 
individuals with substance use disorders. Future neuroimaging studies of attentional tasks and 
craving paradigms in individuals with addictions who have received mindfulness training will 
help to test this and other hypotheses regarding the mechanism of mindfulness and its effects on 
brain activation.  
The second major component of mindfulness, acceptance, involves a non-judging/non-
attached, “objective” view of experiences. This perspective, referred to as “de-centering” or 
- 10 - 
“meta-cognition” (72), leads to an understanding of thoughts and sensations as “transient mental 
events” rather than as reality or a reflection of the self. As with attentional focus, de-centered 
observation has been hypothesized to reduce perpetuation of harmful thought patterns by shifting 
one’s perspective away from automatically regarding uncomfortable or unpleasant thoughts as 
“real” or “true,” and instead cultivating a more open attitude that recognizes such thoughts as 
merely passing mental events. Awareness of thoughts that might arise improves tolerance of 
negative affect, lessens reactivity, and decreases attempts to avoid or suppress experience, 
measures which have all been linked to worsened outcome (73, 74). It should be noted here that 
as the capacity for acceptance is emphasized and reported to be beneficial in mindfulness 
training as well as therapies that incorporate mindfulness such as Acceptance Based Therapy 
(ACT) and Dialectical Behavioral Therapy (DBT) (75, 76), it is yet unclear whether a de-
centered viewpoint fosters acceptance, acceptance fosters a de-centered viewpoint, or whether 
the effects are bidirectional.  
It has been posited that much emotional reactivity is rooted in self-referential thinking, 
and that by reducing this secondary emotional processing, meditators “experience less stress and 
react to problems with greater composure and equanimity” (74). Indeed, Farb and colleagues 
have provided some of the first evidence in favor of this perspective with their functional 
connectivity analysis, which revealed a decoupling of insular-ventromedial prefrontal cortical 
(vm-PFC) activity and an increased coupling of the insula with the dorsolateral prefrontal cortex 
(dl-PFC) with mindfulness training (17). In further support of these findings, meditation practice 
has been associated with a thickened right insular cortex, somatosensory cortex, inferior 
temporal gyrus, and inferior parietal lobule (77, 78). These data suggest a movement away from 
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self-referential experiences (associated with midline structural activation) toward those that are 
more objectively observed. 
This non-attached vantage point may explain the effectiveness of mindfulness for 
prevention of depression relapse in MBCT, which posits that emotional challenges are often 
closely connected to thoughts, and which trains individuals to recognize thoughts as “mental 
events” rather than “reality” (10). As in the case of attentional tasks and craving paradigms for 
individuals with substance use disorders, future neuroimaging studies will help identify neural 
correlates of these processes, furthering progress toward a greater understanding of mindfulness’ 
specific mechanisms of action. 
The utility of a de-centered mode of processing experience in individuals with addictions 
is becoming increasingly clear. The majority of individuals with substance use disorders report 
experiencing “urges” to use substances and state that the experience of an urge is increasingly 
tolerated and managed when working with a mindfulness approach (6, 79-81). In addition, 
decreases in substance use following engagement in meditation training have been shown to be 
partially mediated by decreased avoidance, but not decreased frequency, of intrusive thoughts 
(4).  
Meta-cognitive skills developed through practice of mindfulness can be delineated as 
follows: the ability to sustain attention, shift attention, inhibit secondary elaborative processing 
of objects of awareness, and process information related to current experience since attentional 
capacity is not being consumed by elaborative thinking (9, 16). Because mindfulness involves 
enhancement of attentional control and increased awareness of mental and behavioral process, it 
holds promise as a tool for interrupting patterns of self-destructive habitual thoughts and 
behaviors (6, 10, 19, 21, 82, 83). Development of a defined, prescribed attitude toward 
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experience is thought to decrease avoidance of negative aspects of experience, thereby increasing 
tolerance of negative affect and raising emotional awareness (9).  
Another important aspect of mindfulness training is the concept of compassion. 
Compassion practice has shown effects on stress induction and immune function (84). Expert 
meditators have demonstrated increased activity in the insula when practicing compassion 
meditation, which is based on generating feelings of “loving kindness,” and which has been 
hypothesized to affect emotional responses to stimuli (85). Additionally, these practices are 
increasingly being incorporated into mindfulness-based relapse prevention programs (79). 
Whether these practices foster meta-cognitive skills, increase acceptance, or have other 
mechanistic utility remains to be determined. Future work in defining and measuring compassion 
practices both in basic science and clinical realms will move us closer to understanding their 
neural mechanisms and therapeutic efficacy. 
One potentially important aspect of mindfulness training, particularly interesting in the 
context of treatment of substance use disorders, is the practice of “abstinence” (86), i.e., response 
prevention by sitting motionless and abstaining from impulsive reaction to both pleasant and 
painful thoughts or feelings. The behavioral practice of non-reaction might “de-link” the 
thought/feeling from the response (86), moderating maladaptive habitual behaviors. Future 
studies might compare traditional mindfulness vs. more standard behavioral treatment in the dual 
diagnosis population. 
Despite the efficacy of mindfulness based therapies in the treatment of a variety of stress-
related disorders, as well as the extensive theoretical benefits of applying mindfulness training to 
the treatment of addictions as outlined above, to date no randomized controlled trials have been 
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run comparing MT to empirically validated treatments for substance use disorders, such as CBT 
(87). 
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II. Statement of Purpose 
The purpose of this investigation was to engage in the first randomized, controlled trial of 
a manualized mindfulness based therapy for the treatment of substance use disorders. This report 
describes the clinical and laboratory outcomes from a Stage I pilot trial in which a manualized 
version of MT was modified for individuals with substance use disorders, and the following 
specific parameters were evaluated: (1) MT’s feasibility compared with another empirically 
validated therapy (CBT); and (2) MT versus CBT’s subjective and objective effects on stress, as 
evaluated by both self-report measures and reactivity during stress provocation using a stress 
paradigm established in previous studies on stress and addiction (88). The hypotheses to be 
tested in this investigation were: (1) MT would be tolerated equally as effectively as CBT in 
terms of retention rates and subjective measures of treatment tolerability; (2) Participants 
undergoing MT would demonstrate reduced reactivity on both subjective and objective measures 
during stress provocation as compared with CBT; and (3) Participants undergoing MT would 
have reduced substance use as compared with CBT following completion of the intervention. 
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III. Methods 
Participants 
Participants were recruited from media advertisements and clinician referrals for 
individuals seeking treatment at the Substance Abuse Treatment Unit (SATU), a 
community-based outpatient treatment facility in New Haven, CT. Participants were 
English-speaking adults who met DSM-IV criteria for alcohol and/or cocaine abuse or 
dependence in the past year. Exclusion criteria were minimal to facilitate recruitment of a 
clinically representative group of individuals seeing treatment in a community setting. 
Thus, individuals were excluded only if they were currently at clinically significant risk 
for suicide or homicide, had a current psychotic disorder, were cognitively impaired to 
the point where they were unable to complete clinic demographic or study-related 
questionnaires, were on beta-blocker treatment (which may influence heart rate 
measurements), or were intoxicated at the time of initial study interview.  
As shown in the participant flow diagram (Figure 1), all of the 36individuals who 
were screened were determined to be eligible for the study, provided written informed 
consent, and were randomly assigned to a treatment condition (MT or CBT), following a 
complete description of the study and provision of written informed consent approved by 
the Yale University School of Medicine’s Human Investigations Committee. Of the 36 
subjects assigned to treatment, 25 were exposed to their protocol treatment and 14 
completed treatment. Thus, full outcome data are available only for the 14 individuals 
who completed treatment. Laboratory data are available for the 13 participants who 
completed treatment and the lab session as described below. 
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Treatments 
All participants received weekly group treatment that was matched for time 
(approximately one hour, once weekly). All treatments were manualized and delivered by 
PhD-level therapists experienced in CBT or MT respectively. CBT was used for the 
comparison condition because of its well-established role in the non-pharmacologic 
treatment of substance use disorders, as described above. Groups were structured in a 
psychoeducational format, allowing for both experiential discussion and didactic 
instruction. This investigator was involved in the testing and adaptation of the MT format 
for the purposes of this study. 
CBT was delivered by one PhD-level therapist using the National Institute on 
Drug Abuse (NIDA) CBT manual over a 12-week period (89). Groups were delivered in 
a continuous fashion and individuals could enter based on a weekly rolling admission 
process. Groups were capped at eight to ensure optimal treatment.  
Participants randomized to MT received a modified form of manualized group 
Mindfulness-Based Relapse Prevention (MBRP) over a nine-week period (3, 82). Briefly, 
the MBRP course is based on MBSR and traditionally delivered via eight, two-hour 
weekly group sessions. Participants are taught relapse prevention techniques through 
learning to attend mindfully to relapse triggers such as thoughts, emotions, and bodily 
sensations. Themes for the eight sessions of MBRP are as follows: “1. Automatic pilot 
and its relation to craving”; “2. Triggers, thoughts, emotions and cravings”; “3. 
Mindfulness in everyday life”; “4. Staying present and aware in high-risk situations”; “5. 
Balancing acceptance and change”; “6. Seeing thoughts as just thoughts”; “7. How can I 
best take care of myself? Build support networks and taking action”; and “8. Balanced 
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living and using what has been learned.” During sessions, individuals learned various 
meditation techniques, including sitting and walking meditations as well as “urge 
surfing” techniques to help them tolerate urges as they arose. 
Three major adaptations to MBRP were implemented. First, after the initial 
session (renamed Introduction), the seven sequential sessions were divided into two, 
four-week modules that could be completed in either order (i.e., Introduction, then 
Module 1, then Module 2; or Introduction, then Module 2, then Module 1). This was 
done to assess “real-world” delivery of the treatment by providing minimal waiting time 
for individuals to enter treatment. Another benefit was to facilitate equal pre-group clinic 
intake periods for individuals who were randomized to MT or CBT (roughly 3 weeks 
from initial clinic intake and individual clinician evaluation to the start of group treatment 
for both groups). Module 1 included sessions 2, 6 and 7. Two additional sessions were 
added: the first specifically targeted working with anger as a trigger for stress, drug use or 
relapse (90), and had originally been developed for MBSR, while the second involved 
instruction for using compassion-based loving-kindness/“metta” techniques to facilitate 
working with difficult emotions or thoughts as part of MT (91). Module 2 included 
sessions 3, 4, 5, and 8. 
The second major adaptation was the elimination of yoga meditation from the 
training in order to minimize the possibility of confounding effects, especially given 
evidence for yoga’s potential beneficial effects as a stand-alone treatment for stress 
reduction and drug use (92, 93). 
The final major adaptation was to shorten the weekly sessions to approximately 
one hour each (mainly by shortening the guided meditation exercises). This was done for 
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two reasons: 1) as the “dose-response” curve for mindfulness acquisition and treatment 
has not been determined, we wanted to determine whether shorter sessions would be 
sufficient for individuals to attain adequate mindfulness skills for benefits to be seen; and 
2) we wanted to mimic as closely as possible group community session length—which, 
as with the CBT sessions, is typically approximately one hour in length.  
 
Assessments 
Participants were assessed before treatment initiation, weekly during treatment, 
and at the time of treatment termination. Participants were administered the Structural 
Clinical Interview for DSM-IV (SCID) alcohol and drug use sections before 
randomization in order to establish substance use diagnoses (94). This investigator was 
trained to administer the SCID alcohol and drug use sections. Diagnoses were confirmed 
by an individual evaluation by a psychiatrist. The Substance Use Calendar was 
administered weekly during treatment to collect detailed day-by-day self-reports of drug 
and alcohol use throughout treatment (95). Participant self-reports of drug use were 
verified by random breathalyzer and urine toxicology screens (approximately once every 
two weeks). One hundred percent of the breathalyzer and 98.4% (62/63) of the urine 
specimens were consistent with participant self-report. 
A variety of psychometric and self-report measures were used to assess study 
participants. This investigator was involved in the research, compiling, and adaptation of 
these measures for the purposes of this investigation. The Five Facet Mindfulness 
Questionnaire (FFMQ), a 39 item self-reported psychological measure of mindfulness 
skills, was administered at baseline and treatment completion to assess mindfulness skills 
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acquisition (96, 97). The items are presented on a 5-point Likert scale ranging from 1 
(almost always) to 5 (almost never). The Treatment Credibility Score questionnaire 
(TCS), an eight item self-reported measure of treatment acceptability was administered at 
the end of treatment. The TCS consisted of questions related to how agreeable and 
practical each treatment was for drug use, depression and anxiety, and was also rated on a 
5-point Likert scale ranging from 1 (not at all) to 5 (very much). Questions included: 
“How confident do you feel that your therapy can help with your drug/alcohol use?”; 
“How much does it make sense to you that your therapy would help with drug/alcohol 
use?”; and, “How confident do you feel recommending your therapy to a friend with 
similar problems?”  
 
Laboratory Paradigm  
At the conclusion of treatment, subjects participated in a single one-hour 
laboratory session that included two imagery conditions: one with neutral-relaxing 
imagery and the other with stressful imagery (29, 31, 33, 88, 98-100). In a separate 
session several weeks prior to the laboratory session, these imagery scripts had been 
developed for both the stress and neutral-relaxing situations as (29, 31, 33, 88, 98, 99). 
The stress imagery script was developed by having subjects identify a recent stressful 
experience they had personally experienced as “most stressful.” The quality of “most 
stressful” was determined by asking the subjects to rate an experience perceived as 
stressful by them in the past year on a 10-point Likert scale, where 1 = “not at all 
stressful” and 10 = “the most stress they have felt in the past year.” Only situations rated 
as 8 or above on this scale were accepted as appropriate for script development. Stressful 
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situations related to drug use were not allowed. Examples of acceptable stressful 
situations include unemployment-related stress, such as being fired from work, or a 
verbal argument or physical altercation with a significant other or family member. The 
neutral-relaxing script was developed from a commonly experienced relaxing scene that 
did not include drug or alcohol use (e.g., reading a book in bed, listening to music, 
walking on the beach). Each script was edited by two individuals who were blinded to 
treatment group to ensure consistency between participants. Scripts were then digitally 
recorded by a female research associate who was blinded to treatment condition and 
unknown to participants.  
Approximately 45-60 minutes before each laboratory session, participants were 
fitted with skin conductance electrodes on the non-dominant hand to measure galvanic 
skin responses (GSR), a respiratory rate monitor, and two electrocardiogram (ECG) leads 
to measure heart rate and heart rate variability (HRV). This allowed for acclimatization 
before the start of the laboratory sessions. At this time the participants were taught 
relaxation procedures to help them follow the guided relaxation before the start of each 
script, such that they were in a standardized, relaxed state at the onset of each script. 
Physiological measurements were recorded using a Biopac MP100 system running 
AcqKnowledge 3.9 software (Biopac Systems Inc., USA). The Biopac electrodermal 
activity amplifier module (GSR 100c) was set at a channel sampling rate of 31 Hz and a 
gain of 5 µSiemens (µS) per volt (resulting in a resolution of 0.0015 µS), the 
electrocardiogram amplifier (ECG 100c) was set at a channel sampling rate of 1000 Hz 
for the laboratory sessions, and the respiratory amplifier (RSP 100c) was set at a channel 
sampling rate of 62.5 Hz. 
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Participants were seated in a comfortable reclining chair for the duration of the 
laboratory session and were separated by a physical partition from the experimenter. 
Each imagery condition was presented in a 30-minute block, beginning with guided 
relaxation before presentation and an 8-minute recovery period between conditions. The 
order of the stress and neutral-relaxing imagery scripts was randomized for each subject. 
The subject was not informed of the order of imagery conditions. The recorded scripts 
were played via noise-reduction headphones (iTunes, Apple Inc., USA). Subjective 
responses after each script were recorded on a laptop computer positioned next to each 
participant using the ePrime software package v. 2.0 (Psychology software Tools Inc. 
USA). 
After each imagery script was played, participants rated situational vividness on a 
10-point visual analog scale (VAS, with 1 = not at all clear, and 10 = perfectly clear 
image) for how "clearly and vividly" they were able to imagine the scenario. Participants 
then rated their anxiety and drug/alcohol cravings on a 10-point visual analog scale 
(VAS) for each condition. Subjects also completed an abbreviated 30-item version of the 
Differential Emotion Scale after each condition, in which five adjectives are used to 
describe each of six emotional states and subjects are asked to rate on a 5-point Likert scale 
the extent to which each word describes the way they feel at the present time (DES; (101)). 
In the laboratory sessions, average vividness ratings for the stress imagery were 8.1 + 1.1 
and 8.6 + 0.5 for MT and CBT, respectively, average vividness ratings for the neutral 
imagery were 8.0 + 1.1 and 8.2 + 0.4 for MT and CBT, respectively, with no significant 
differences between the groups or conditions. 
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Data Analysis 
This investigator was responsible for extracting and compiling the subjective and 
objective data obtained during this study, which involved extensive communication and 
collaboration with the makers of the AcqKnowledge software in order to convert data for 
heart rate, heart rate variability, respiratory rate, and galvanic skin responses into an 
applicable format (as described below). 
The principal data analytic strategy was analysis of variance (ANOVA) for 
between-group comparisons of drug use and scores on the FFMQ and TCS. Chi-square 
analysis was used to determine treatment retention differences. DES, anxiety and drug 
craving VAS scores were compared by 2-tailed t-tests. A within-subjects ANOVA was 
used to evaluate GSR differences by treatment condition (between subjects) and testing 
condition (within subjects). GSR “events” were thresholded at 0.05 µS with a 0.05 µS 
high pass filter applied and responses under 10% of maximum were excluded (of note, a 
post-hoc analysis with no thresholds yielded essentially unchanged numbers of events in 
all participants). Stress reactivity was calculated by subtracting the mean skin 
conductance from the maximum skin conductance within each testing condition (stressful 
and neutral) using a covariate of a five-minute period before each condition to control for 
baseline GSR measurements. These models were also run on the mean skin conductance, 
the maximum skin conductance, and the number of GSR events, or stress reactivity score. 
Within-subjects ANOVAs were run on the mean skin conductance, the maximum skin 
conductance, the number of GSR events, or stress reactivity score with treatment 
condition, testing condition, and the interaction of treatment and testing condition as the 
predictors.  
- 23 - 
Within-subjects ANOVAs evaluated influences of sympathetic and vagal tone, 
with treatment condition, testing condition, and the interaction of treatment and testing 
condition as the predictors using HRV power algorithms. Briefly, ECG heartbeat 
dropouts were manually filtered, then each PQRST complex was bandpass filtered at 17 
and 5 hz to create discrete signal nodes. From these nodes, power spectral density 
analysis was performed using AcqKnowledge 3.9 software. The sympathetic ratio was 
defined as the percentage of the power spectral density (P) that occurs in the low 
frequency band (0.04 - .15 Hz): (P_Low) / (P_High + P_Low). The vagal ratio was 
defined as the percentage of the power that occurs in the high frequency band (.15 - .4 
Hz): (P_High) / (P_High + P_Low) (102). The sympathetic/vagal ratio was calculated 
from dividing the sympathetic by the vagal ratio.  
Data are reported as mean + standard error of the mean unless otherwise noted. 
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IV. Results  
Group Description 
Table 1 presents baseline demographic and substance use characteristics of the 36 
individuals who were randomized for this study. Most of the participants (72%) were 
male, 64% were White, 24% Black, and 12% Hispanic. Most were single or divorced 
(76%), did not have a college degree (76%), and were not employed full-time (72%). The 
majority met SCID criteria for alcohol dependence (68%) and/or cocaine dependence 
(48%). Analysis of variance and chi-square analysis indicated no significant differences 
by treatment condition except that more participants assigned to the CBT group were 
married (57%) than in the MT group (6%) (F/X
2
 = 8.5, p = .04). No differences in 
baseline drug or alcohol use were found between individuals who completed treatment 
and those who did not complete treatment.  
 
Feasibility: Treatment retention, satisfaction, and substance use outcomes 
To evaluate the feasibility and acceptability of MT relative to a more established, 
empirically validated therapy (CBT), we compared retention across the two treatment 
conditions. Of the 36 individuals who entered the study, 9/21 (43%) completed MT, 
while 5/15 (33%) completed CBT (p = .563, Figure 1). Of those who initiated treatment, 
participants attended 65% of expected sessions in MT vs. 34% of sessions in CBT (F = 
4.89, p = .04, Figure 2). Participants who completed treatment in both groups rated their 
treatments as highly satisfactory as assessed by TCS (4.2 + .18 for MT vs. 4.4 + .21 for 
CBT, p = .37).  
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Despite active cocaine or alcohol use in the month prior to treatment initiation in 
8/9 (89%) of completers in the MT group and only 2/5 (40%) in the CBT group, we 
found that substance use did not differ by treatment groups. Of the completers, the 
percent of days of cocaine use during treatment was 5.4 + 2.7 in MT vs. 0.0 + .00 in CBT 
groups (F = 2.1, p = .17). The percent of days of alcohol use during treatment was 24.3 + 
9.4 vs. 0.0 + .00 in MT vs. CBT groups (F = 3.6, p = .09). 
 
Specificity of MT: Effects of Treatment on Mindfulness Skills Acquisition and 
Implementation 
To determine whether the paradigm employed in this investigation adequately 
fostered mindfulness skills development, the FFMQ was measured before and after 
treatment. There were no observed differences in the FFMQ between groups at baseline 
(MT = 126.5 + 5.6, CBT = 122.6 + 6.0, p = .64). Additionally, no differences were noted 
between completers at baseline (MT = 122.1 + 8.6, CBT = 118.8 + 12.9, p = .82). 
Although participants in the MT group showed greater overall increases in FFMQ scores 
compared to CBT after treatment, these differences did not reach statistical significance 
(MT = 144.2 + 6.1; CBT = 131.4 + 12.2, p = .04 by time, p = .54 group by time). These 
gains were primarily seen in the observing (p = .01 by time, p = .44 group by time), non-
judging of experience (p = .03 by time, p = .87 group by time), and the non-reactivity to 
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Specificity of MT: Subjective and Objective Responses to Stress Provocation 
To determine whether MT differentially influences psychological responses to 
stress, responses to a personalized stress challenge were compared for individuals who 
completed MT vs. CBT. Participants who received MT showed significantly attenuated 
anxiety in both VAS and DES scores in stress vs. neutral conditions compared to those 
who received CBT (VAS: 1.5 + .68 for MT vs. 4.6 + .73 for CBT, p = .01, Figure 3a; 
DES: 1.50 + 1.7 for MT vs. 7.0 + 1.4 for CBT, p = .03, Figure 4). These attenuations 
were echoed in attenuated responses in several other negative emotions (Figure 4). 
Though not statistically significant, individuals receiving MT also reported roughly half 
the levels of stress-induced drug craving compared to those receiving CBT (1.1 + 1.3 vs. 
2.0 + 1.4, p = .65, Figure 3b). 
Another goal was to determine whether MT would exert any influence on 
physiological measures of stress. We found large differences in galvanic skin responses 
between stress and neutral stories that were not different between groups (MT: 10.0 + 2.9 
for stress vs. 4.5 + 2.6 for neutral; CBT: 7.0 + 2.9 for stress vs. 0.8 + .49 for neutral, F = 
12.36, p = .01 for condition). Additionally, no differences were noted in respiratory rate 
(data not shown). However, whereas the expected increases in maximum heart rate 
during stress were observed in the CBT group, no increases in were seen in the MT group 
(81.4 + 2.5 vs. 98.7 + 16.8, F = 1.97, Figure 5a). These findings were not significant (p = 
.19), but the η
2
 showed this effect size to be large (0.15; scores >.14 are considered 
“large”). Corresponding differences were seen in heart rate variability measures: 
individuals in the MT group showed decreased sympathetic/vagal ratios, a measure of 
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autonomic activation, when compared to those in the CBT group (4.01 + .18 vs. 4.20 + 
.10, F = 7.97, p = 0.02, effect size = .42, Figure 5b). 
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V. Discussion 
Overall conclusions 
This Stage I pilot trial sought to evaluate both the feasibility and specificity in 
terms of stress reactivity of manual-guided MT versus CBT for individuals with 
substance use disorders. Although attrition in both groups was substantial, MT did not 
differ from CBT in participant retention, treatment satisfaction, or frequency of substance 
use. However, those who completed MT demonstrated attenuated psychological and 
physiological responses to stress provocation compared to those participants who 
completed CBT. While the sample size was small and the results preliminary, this 
investigation represents the first randomized clinical trial comparing MT to an 
empirically validated treatment for substance use disorders, and the first to assess 
responses to stress provocation in this population. It adds to the emerging positive 
literature on MT for addictions by extending it to randomized controlled trials, as well as 
evaluating MT’s effects on indices of stress reactivity a major trigger for use/relapse (29, 
99).  
 
Stress and Addiction 
As noted above, stress has been shown to activate neural circuitry important in 
addictions, induce cravings, and lead to relapse (29-32). The stress paradigm described in 
this study provided robust psychological and physiological responses as evidenced by 
increases in emotional and craving ratings, and increases in GSR and HR measures. 
Importantly, the number of GSR events increased in stress vs. neutral stories in both 
groups, which suggests that all individuals engaged in, and thus did not employ 
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avoidance or suppression strategies, while listening to stressful stories. Such strategies 
have been shown to lead to increased numbers of intrusive drug-related thoughts (70) and 
linked to worse outcomes (73, 74). Importantly, the results of this investigation showed 
that subjective measures of stress were reduced in MT compared to CBT during stress 
provocation. This is consistent with the idea that MT fosters an active but non-attached 
participation in events (including cravings and stressful situations) (22, 103). It has been 
proposed that emotional reactivity is rooted in self-referential thinking, and that by 
reducing this secondary emotional processing, people trained in mindfulness may 
respond to stressful events with greater composure and equanimity (74). Indeed, Farb and 
colleagues have shown a decoupling of brain regions involved in sensing bodily states 
(insula) from those that are thought to be involved in self-reference (medial prefrontal 
cortex) after MT (17).  
In addition to differences in self-reported anxiety and emotion, we also found 
objective evidence of differences in stress reactivity after MT. Previously, we and others 
have found increases in HR indices in individuals with addictions undergoing stress (33, 
104, 105). In this study, the data demonstrate an attenuation of increase in HR among the 
MT group but not the CBT group. This finding provides objective corroboration of 
individuals’ report of attenuated anxiety and negative emotions.  
Sympathetic and vagal tone, which reflect autonomic nervous system (ANS) 
activity, were calculated as additional measures of subject arousal. ANS activity is 
important for psychological and physiological allostasis (106-109). The two major 
branches are the sympathetic ANS, associated broadly with energy utilization (i.e., “fight 
or flight” responses) and the parasympathetic ANS, associated with restorative functions 
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(110). The heart is dually innervated by both the sympathetic and parasympathetic (vagus 
nerve) branches of the ANS (102, 110). In healthy individuals, the heart is under tonic, 
parasympathetic inhibitory control. This allows for adaptive responses to environmental 
conditions given the short time course of parasympathic effects (milliseconds) compared 
to sympathetic effects (seconds) (110). ANS imbalance, often characterized by 
predominance of the sympathetic branch, has been linked to a range of pathological 
conditions (111).  HRV represents a reliable index of ANS balance and has been 
associated with increased mortality (112).  
In this study, the data demonstrate a decreased sympathetic/vagal ratio among 
participants in the MT compared to the CBT group. This finding is consistent with the 
idea that MT promotes a de-centered stance toward environmental stimuli: as individuals 
are able to engage but not be “caught up” in thoughts or emotions, they are more able to 
adapt to changing internal and external environmental cues and conditions. As vagal tone 
has been shown to be a peripheral indicator of prefrontal cortical control of downstream 
sympathetic responses (e.g., anxiety and/or fear) (113), decreases in the 
sympathetic/vagal ratio also suggest the possibility of prefrontal cortical circuits playing 
a mechanistic role in MT’s mediation of stress. This is an intriguing possibility as we 
have previously found that prefrontal cortical activation during a cognitive control task 
(Stroop) is associated with improved treatment outcomes (114). Future studies using 
functional magnetic resonance imaging will help to determine specific brain regions that 
may be altered by MT and how this affects individual responses to stress.  
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Treatment implications 
 In this preliminary evaluation of the feasibility of MT, manual-guided MT was 
not significantly different from group CBT in treatment retention, substance abuse 
outcomes, or participant satisfaction with treatment. There are several important 
implications from these findings, as 1) MT has not previously been compared head-to-
head to CBT, 2) the length of sessions was significantly shortened compared to standard 
mindfulness-based paradigms and 3) MT was delivered in a modular rather than 
sequential format. First, although preliminary given our small sample sizes, these data 
suggest that MT may be a viable treatment strategy. Second, individuals who have 
undergone mindfulness training through programs that utilize sequential sessions of 
approximately two hours a week for eight weeks have shown self-reported mindfulness 
“acquisition” which has recently been shown to correlate with outcomes (115). However, 
the “dose-response” curve for mindfulness acquisition and treatment delivered in a block 
design has not been studied. These data suggest that shorter MT sessions may still 
provide enough training to establish efficacy. Third, these results suggest that a modular 
format is a viable delivery option. 
The latter two points have important implications for community-based treatment 
programs. Developing treatments that are shorter than typical mindfulness-based 
approaches will be more viable financially for community clinics and are less of a time 
burden for patients, ultimately supporting their attendance and treatment completion. 
Additionally, providing modular formats may be hypothesized to reduce logistical 
administrative burdens and allow for fewer trained therapists to treat a great number of 
patients. Such an effect has been successfully demonstrated in programs such as 
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dialectical behavioral therapy (116). However, future studies directly comparing modular 
vs. sequential delivery will be important in order to test these hypotheses. 
 
Strengths and Limitations 
Strengths of this trial include random assignment of a diverse group of 
participants in and representative of a community clinic, a robust, validated laboratory 
stress paradigm that utilized discrete psychological and physiological measures, and the 
use of CBT as the comparison condition, which provides good controls over attention, 
activity level, and therapist involvement. 
This study has several limitations as well. In particular, the sample size was small 
and outcome data were based on the minority of individuals in both conditions who 
completed treatment. Also, it included a heterogeneous population both in substance use 
disorders (alcohol and cocaine) and drug use status at study entry. Although this arguably 
provides greater ecological validity, enrolling only individuals who were actively using a 
single substance at study entry may have provided more homogenous data with regards to 
substance use outcomes. Additionally, this study was performed at a single site using 
single therapists for each condition and measures of treatment fidelity or discriminability 
were not included. The randomization of subjects resulted in uneven groups, with 
differences in one of the demographics (marital status) approaching statistical 
significance. While there are no known explanations for this discrepancy, it may have 
had some impact on the study. Finally, given the robustness of CBT as an evidence-
based, non-pharmacological treatment for relapse prevention in addictive disorders, its 
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use in the control condition may have made it more difficult to detect subtle treatment 
benefits attributable to MT.  
Despite these concerns, this randomized-controlled pilot study suggests that MT 
may have promise as a component of addiction treatment, and that further studies of its 
effects on stress reactivity may be warranted.  
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VII. Figure references and legends 
 
 
FIGURE 1. CONSORT Diagram: Flow of Participants Through the Study Protocol. 
CBT = Cognitive Behavioral Therapy, MT = Mindfulness Training 
 




FIGURE 2. Subjects Receiving MT Showed Increased Treatment Retention. 
Treatment retention was calculated from the number of sessions attended divided by the 
total number of sessions. 








FIGURE 3. Mindfulness Training is Associated with Attenuated Anxiety with Stress 
Provocation. Y-axis denotes reported visual analog scale (VAS) scores after listening to 
personalized neutral or stressful stories. a) Anxiety scores; bars on far right indicate 
normalized scores (stress minus neutral). b) Normalized drug craving scores (stress minus 
neutral). ** indicates p = 0.01 between treatment groups. 
** 
** 
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FIGURE 4. Mindfulness Training is Associated with Attenuated Emotional Reactivity. 
Y-axis denotes normalized Differential Emotion Scale scores after stress provocation 












FIGURE 5. Mindfulness Training is Associated with Lower Maximum Heart Rate and 
Sympathetic Tone During Stress Provocation. a) Heart rate during neutral and stressful 
stories. b) Percent change in sympathetic/vagal ratio in stress versus neutral stories. 
* indicates F = 7.97 in treatment by condition (p = .02).
* 
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VIII. Tables 
 
TABLE 1. Baseline Demographic Variables and Substance Use by Treatment Condition 
 CBT (N=15) MT (N=21) Total (N=36)     
Sex N (%)   N (%)   N (%)   F/X
2 
 df p 
   Male 5(71.4)  13(72.2)  18(72)  0.002 1 .968 
   Female 2(28.6)  5(27.8)  7(28)     
Race          
   White 6(85.7)  10(55.6)  16(64)  3.092 2 .213 
   Black 0  6(33.3)  6(24)     
   Hispanic 1(14.3)  2(11.1)  3(12)     
Education level          
   College or grad school 3(42.9)  2(13.3)  5(22.7)  3.216 2 .200 
   Partial college 1(14.3)  7(46.7)  8(36.4)     
   High school/GED or part. HS 3(42.9)  6(40)  9(40.9)     
Marital status          
   Never married 2(28.6)  11(61.1)  13(52)  8.504 3 .037 
   Married 4(57.1)  1(5.6)  5(20)     
   Separated 0  1(5.6)  1(4)     
   Divorced 1(14.3)  5(27.8)  6(24)     
Employment Status          
   Full time 6(40)  4(19)  10(27.8)  2.843 3 .417 
   Part Time 3(20)  8(38.1)  11(30.6)     
   Unemployed lt 1 month 1(6.7)  3(14.3)  4(11.1)     
   Unemployed gt 1 month 5(33.3)  6(28.6)  11(30.6)     
Occupational level          
   Higher executive 0  1(5.9)  1(4.2)  5.906 5 .315 
   Business manager RN 3(42.9)  4(23.5)  7(29.2)     
   Administrative 2(28.6)  1(5.9)  3(12.5)     
   Clerical or sales 1(14.3)  1(5.9)  2(8.3)     
   Skilled manual 1(14.3)  6(35.3)  7(29.2)     
   Machine operator 0  4(23.5)  4(16.7)     
Alcohol SCID Diagnosis          
   Absent 2(28.6)  5(27.8)  7(28)  0.407 2 .816 
   Dependence 5(71.4)  12(66.7)  17(68)     
   Abuse 0  1(5.6)  1(4)     
Cocaine SCID Diagnosis          
  Absent 5(71.4)  8(44.4)  13(52)  1.47 1 .225 
  Dependence 2(28.6)  10(55.6)  12(48)     
   Abuse 0  0  0     
          
MJ positive baseline 0  3(21.4)  3(15)  1.513 1 .219 
Cocaine positive baseline 0  3(21.4)  3(15)  1.513 1 .219 
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TABLE 1 Continued 
 CBT (N=15) MT (N=21) Total (N=36)     
 Mean+SD N Mean+SD N Mean+SD N F df p 
 
Age 45+13.5 7 35.6+10.4 18 38.2+11.9 25 3.487 1 .075 
Years of 
    Education 13.7+2.2 7 13.1+2.4 18 13.2+2.3 25 .386 1 .541 
Days of alcohol use in the 
past 28 days 0 5 .06+.24 17 .05+.21 22 .284 1 .600 
Days of Marijuana use in 
the past 28 days 0 5 .19+.40 16 .14+.36 21 1.044 1 .320 
Days of cocaine use in 
the past 28 days 0 5 .06+.24 17 .05+.21 22 .284 1 .600 
Days of tobacco use in 
the past 28 days .20+.44 5 .53+.52 15 .45+.51 20 1.654 1 .215 
Number of inpatient 
psychiatric treatments .57+1.5 7 .56+1.0 18 .56+1.1 25 .001 1 .975 
Number of outpatient 
psychiatric treatments 1.3+2.0 7 .56+1.2 18 .76+1.5 25 1.291 1 .268 
Number of inpatient drug 
treatments .71+1.1 7 1.3+1.6 18 1.2+1.5 25 .899 1 .353 
Number of outpatient 
drug treatments .86+1.5 7 .89+.96 18 .88+1.1 25 .004 1 .950 
Age of first 
    alcohol use 13.8+2.0 5 12.5+2.6 8 13+2.34 13 .941 1 .353 
Age of first 
    cocaine use 13.5+17.2 4 17.6+3.7 7 16.1+10.1 11 .390 1 .548 
 
